- Filed
- Feb 27, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 18, 2025 | 63.2M sh |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $220.25M |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | $467.06M |
| Current Liabilities restated | FY 2024 · Dec 31, 2023 | $362.51M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $821.83M |
| Current Assets | FY 2024 · Dec 31, 2023 | $876.78M |
| Total Assets | FY 2024 · Dec 31, 2023 | $1.29B |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 63.69M sh |
| Capex | FY 2024 · Dec 31, 2022 | $46.97M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | $160.68M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | $2.77 |
| Eps Basic | FY 2024 · Dec 31, 2022 | $2.80 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $132.79M |
| Rd Expense | FY 2024 · Dec 31, 2022 | $10.4M |
| Net Income | FY 2024 · Dec 31, 2022 | $176.3M |
| Operating Income | FY 2024 · Dec 31, 2022 | $205.8M |
| Gross Profit | FY 2024 · Dec 31, 2022 | $360.71M |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $1.81B |
| Revenue | FY 2024 · Dec 31, 2022 | $2.17B |